BioxelPharma inc.

Bioxel is a biopharmaceutical company focused on the manufacture and distribution of taxane pharmaceutical ingredients including paclitaxel, docetaxel, 9-DHB and 10-DAB. The Corporation has rolled out an integrated taxane manufacturing chain that complies with the pharmaceutical industry's highest standards. Drawing on its high-efficiency processes and exclusive technologies, Bioxel guarantees that its customers are supplied with high-quality taxane products on a reliable and sustainable basis.

To know more

News Releases

  • 2008-08-12 - Bioxel Grants Options to its New President and Chief Executive Officer
  • 2008-07-16 - Appointment of Olivier Meyer as President and Chief Executive Officer of Bioxel Pharma

News Releases Archive

Annual Report 2007 (PDF: 2.07 Mb)

Fact Sheet (PDF: 313 Kb)

 © 2006 BioxelPharma inc. - Terms of use